Skip to main content

Table 2 Plasma levels of LCN2, MMP9 and MMP9/LCN2 complex in nAMD and controls

From: Plasma level of lipocalin 2 is increased in neovascular age-related macular degeneration patients, particularly those with macular fibrosis

Variable (ng/ml)

Control (Mean ± SD)

nAMD (Mean ± SD)

Univariate analysis (p value)

Corrected by age (p value)

Corrected by taking aspirin (p value)

Corrected by taking aspirin and age

 

N = 43

N = 168

    

LCN2

153.24 ± 49.55

181.46 ± 73.62

0.047a 

0.259b

0.602c

0.396d

 

N = 43

N = 167

    

MMP9

124.16 ± 63.12

116.36 ± 68.45

0.274a

   
 

N = 43

N = 167

    

MMP9/LCN2

188.38 ± 45.12

179.16 ± 58.11

0.335a

   
  1. aIndependent samples t test
  2. bUnivariate analysis corrected for age
  3. cUnivariate analysis corrected for taking aspirin
  4. dUnivariate analysis corrected for age and taking aspirin
Back to article page

Immunity & Ageing

ISSN: 1742-4933

Contact us